But the results do reinforce why its important that healthcare providers keep tabs on patients, including on their nutrition and bone health, while using the medications
Evolution of mitochondria as signaling organelles
Human genetics of metabolic dysfunction-associated steatotic liver disease: from variants to cause to precision treatment
This creates significant opportunities for companies to develop companion products that support GLP-1 use and enhance health outcomes
In a study involving healthy non-diabetic subjects, daily intake of a Lactobacillus reuteri SD5865 strain for 8 weeks resulted in an increase of GLP-1 secretion in the intestines, which was accompanied by elevated plasma insulin and C-peptide levels [109]
Recent landmark trials, particularly the SELECT study, have provided compelling evidence for cardiovascular benefits in non-diabetic obese patients, potentially reshaping our understanding of obesity treatment paradigms